Summary
We have examined whether human placental extracts contain tumour-growth-inhibitory factors. One fraction (EAP) from such extracts inhibited growth, in soft agar, ofHa-ras-transformed BALB/c 3T3 cells and human squamous lung carcinoma A-2182 cells. However, this fraction had no effect on the anchorage-dependent growth of these cells, although there was a slight mitogenic activity on nontransformed cells. These data together with those on plating efficiency indicated no significant cytotoxicity of EAP on transformed cell lines. Although this fraction contained transforming growth factorΒ (TGFΒ), this cannot account for its inhibitory activity, since (a) pure TGFΒ does not inhibit anchoragedependent growth of Ha-ras-transformed BALB/c 3T3 cells, (b) EAP retains its inhibitory activity in the presence of antibodies against TGFΒ and (c) the inhibitory activity did not copurify with TGFΒ. Partial characterization of our inhibitory factor suggests that the inhibitory factor is a new tumour-growth-inhibitory factor.
Similar content being viewed by others
Abbreviations
- SDS:
-
sodium dodecyl sulphate
- TGFα orΒ :
-
transforming growth factorα orΒ
- TIF1 or 2:
-
transformed inhibitory factor 1 or 2
- A-2182:
-
human squamous lung carcinoma cell line
- BALB/c 3T3 1-1:
-
mouse fibroblast cell line, clone A31 1-1
- BALB/c 3T3 Ha-ras, BALB/c 3T3 1-1:
-
cells transformed by Ha-ras oncogene
- CHO:
-
Chinese hamster ovary; MEM, minimum essential medium
References
Aklyama SK, Larjava H, Yamada KM (1990) Differences in the biosynthesis and localization of the fibronectin receptor in the normal and transformed cultured human cells. Cancer Res 50:1601–1607
Bischof P, Klopper A (1985) Proteins of the placenta. Biochemistry, biology and clinical application. Karger, Basel
Derynck R, Jarrett JA, Chen EY, Eaton DH, Bell JR, Assoian RK, Roberts AB, Sporn MB, Goeddel DV (1985) Human transforming growth factor-Β complementary DNA sequence and expression in normal and transformed cells. Nature 316:701–705
Enomoto T and Yamasaki H (1984) Lack of intercellular communication between chemically transformed and surrounding untransformed BALB/c 3T3 cells. Cancer Res 44:5200
Foon KA (1989) Biological response modifiers: the new immunotherapy. Cancer Res 49:1621–1639
Friend S, Bernard R, Rogelj S, Weinberg R, Rapaport J, Albert D, Dryja T (1986) A human DNA segment with properties of the gene that predisposes to retinoblastoma and osteosarcoma. Nature 323:643–646
Frolik CA, Dart LL, Meyers CA, Smith DM, Sporn MB (1983) Purification and initial characterization of typeΒ transforming growth factor from human placenta. Proc Natl Acad Sci USA 80:3676–3680
Fryling CM, Iwata KK, Johnson PA, Knott WB, Todaro GJ (1985) Two distinct tumor cell growth-inhibiting factors from a human rhabdomyosarcoma cell line. Cancer Res 45:2695–2699
Fryling C, Dombalagian M, Burgess W, Hollander N, Schreiber AB, Haimovich J (1989) Purification and characterization of tumor inhibitory factor-2: its identity to interleukin 1. Cancer Res 49:3333–3337
Gessler M, Poustka A, Cavenee W, Neves R, Orkin S, Bruns G (1990) Homozygous deletion in Wilms tumours of a zinc-finger gene identified by chromosome jumping. Nature 343:774–778
Giancotti FG, Ruoslahti E (1990) Elevated levels of theα 5 Β 1 fibronectin receptor suppress the transformed phenotype of Chinese hamster ovary cells. Cell 60:849–859
Heino J, Ignotz RA, Hemler ME, Crousse C, Massague J (1989) Regulation of cell adhesion receptor by transforming growth factor-Β. J Biol Chem 264:380–388
Hsuan JJ (1989) Transforming growth factorΒ. Br Med Bull 45:425–437
Ignotz RA, Heino J, Massague J (1989) Regulation of cell adhesion receptor by transforming growth factor-Β. J Biol Chem 264:389–392
Iwata KK, Fryling CM, Knott WB, Todaro GJ (1985) Isolation of tumor cell growth-inhibiting factors from a human rhabdomyosarcoma cell line. Cancer Res 45:2689–2694
Kahn P, Shin S (1979) Test of associations among loss of cell-surface fibronectin, anchorage independence, and tumor-forming ability. J Cell Biol 82:1–16
Kakunaga T, Yamasaki H (1985) Transformation assay of established cell lines: mechanisms and application. (IARC Scientific Publications 67). International Agency for Research on Cancer, Lyon
Klein G (1990) Tumor suppressor genes. Dekker, New York
Laemmli UK (1970) Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 282:619–621
Moses HL, Coffer RJ, Leof EB, Lyons RM, Keski-Oja J (1987) Transforming growth factor-Β regulation of cell proliferation. J Cell Physiol 5:1–7
Plantefaber L, Hynes RO (1989) Changes in integrin receptors on oncogenically transformed cells. Cell 56:281–290
Roberts AB, Sporn MB (1988) Transforming growth factor-Β. Adv Cancer Res 51:107–145
Ruoslahti E, Pierschbacher M (1987) New perspectives in cell adhesion: RGD and integrins. Nature 238:491–497
Sager R (1985) Genetic suppression of tumor formation. Adv Cancer Res 44:43–68
Santos E, Martin-Zanca D, Reddy ER, Pierotti MA, Della Porta G, Barbacid M (1984) Malignant activation of a K-ras oncogene in lung carcinoma but not in normal tissue of the same patient. Science, 223:661–664
Sporn MB, Robert AB, Wakefield LM, Assoian RK (1986) Transforming growth factor-Β: biological function and chemical structure. Science 233:532–534
Towbin HH, Staehelin T, Gordon J (1979) Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc Natl Acad Sci USA 76:4350–4354
Yamasaki H, Katoh F (1988) Further evidence for the involvement of gap junctional intercellular communication and maintenance of transformed foci in BALB/c 3T3 cells. Cancer Res 48:3490
Yamasaki H, Hollstein M, Mesnil M, Martel N, Aguelon AM (1987) Selective lack of intercellular communication between transformed and nontransformed cells as a common property of chemical and oncogene transformation of BALB/c 3T3 cells. Cancer Res 47:5658–5664
Author information
Authors and Affiliations
Additional information
This research was supported by a training grant from Groupement d'Etude et de Recherche sur le Placenta.
Rights and permissions
About this article
Cite this article
Klein, J.L., Hamel, E., Tayot, J.L. et al. Growth suppression of transformed cells by a human placental extract not related to transforming growth factor Β. J Cancer Res Clin Oncol 117, 192–196 (1991). https://doi.org/10.1007/BF01625424
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01625424